Parallax Volatility Advisers, L.P. Eli Lilly & CO Put Options Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $30.2 Million - $37.8 Million	-41,600 Reduced 85.07%	7,300 $6.61 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $2.19 Million - $2.93 Million	-3,700 Reduced 7.03%	48,900 $38 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $11.8 Million - $13.9 Million	22,500 Added 74.75%	52,600 $30.7 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $521,640 - $719,160	-1,200 Reduced 3.83%	30,100 $16.2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.12 Million - $1.5 Million	-3,200 Reduced 9.28%	31,300 $14.7 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4.07 Million - $4.78 Million	-13,100 Reduced 27.52%	34,500 $11.8 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $3.92 Million - $4.57 Million	-12,200 Reduced 20.4%	47,600 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8.42 Million - $9.6 Million	28,400 Added 90.45%	59,800 $19.3 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $8.78 Million - $10.3 Million	-31,500 Reduced 50.08%	31,400 $10.2 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $16.9 Million - $21 Million	-71,900 Reduced 53.34%	62,900 $18 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $27.5 Million - $34.1 Million	-122,100 Reduced 47.53%	134,800 $37.2 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $56.9 Million - $70.1 Million	256,900 New	256,900 $59.4 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $66.4 Million - $81.7 Million	-299,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $7.8 Million - $10.1 Million	-43,200 Reduced 12.61%	299,500 $68.7 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $10.1 Million - $13 Million	-61,300 Reduced 15.17%	342,700 $64 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $52.7 Million - $69.7 Million	404,000 New	404,000 $68.2 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $29.1 Million - $38.6 Million	-223,400 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $16.9 Million - $19.6 Million	-115,900 Reduced 34.16%	223,400 $33.1 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $12.9 Million - $15.5 Million	94,300 Added 38.49%	339,300 $55.7 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $6.73 Million - $8.33 Million	56,500 Added 29.97%	245,000 $34 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $983,664 - $1.22 Million	-9,200 Reduced 4.65%	188,500 $24.8 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $971,789 - $1.06 Million	9,100 Added 4.83%	197,700 $22.1 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $7.07 Million - $8.25 Million	-63,800 Reduced 25.28%	188,600 $20.9 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $18.7 Million - $22 Million	168,100 Added 199.41%	252,400 $32.8 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $12.4 Million - $13.9 Million	-117,500 Reduced 58.23%	84,300 $9.76 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $17.3 Million - $21.7 Million	201,800 New	201,800 $21.7 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $2.27 Million - $2.61 Million	-30,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $371,049 - $438,000	5,000 Added 20.0%	30,000 $2.32 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.93 Million - $2.14 Million	25,000	25,000 $2.14 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$88.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$67.2 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$59.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$46.7 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$30.8 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account